{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:58:59Z","timestamp":1761764339493},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol. Res."],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf00261577","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T13:15:11Z","timestamp":1098191711000},"page":"209-212","source":"Crossref","is-referenced-by-count":6,"title":["Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate"],"prefix":"10.1007","volume":"13","author":[{"given":"W.","family":"Vahlensieck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. D.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Franzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"W\ufffdhlby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"362","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"1971","unstructured":"Armitage P (1971) X2-Test with linear trend. In: Armitage P (ed) Statistical methods in medical research. Blackwell Scientific Publications, Oxford Edinburgh, pp 362?368"},{"key":"CR2","first-page":"253","volume-title":"Prostate cancer","author":"F Edsmyr","year":"1982","unstructured":"Edsmyr F, Andersson L, K\u00f6nyves I (1982) Estramustine phosphate (Estracyt): Experimental studies and clinical experience. In: Jacobi GH, Hohenfellner R (eds) Prostate cancer. Williams and Wilkins, Baltimore London, pp 253?268"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-5347(17)58281-6","volume":"118","author":"SD Foss\u00e5","year":"1977","unstructured":"Foss\u00e5 SD, Foss\u00e5 J, Aakvaag A (1977) Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. J Urol 118:1013?1018","journal-title":"J Urol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/00365598109181211","volume":"15","author":"\u00c5 Fritjofsson","year":"1981","unstructured":"Fritjofsson \u00c5, Norl\u00e9n BJ, H\u00f6gberg B, Rajalakshmi M, Cekan SZ, Diczfalusy (1981) Hormonal effects of different doses of estramustine phosphate (EstracytR) in patients with prostatic carcinoma. Scand J Urol Nephrol 15:37?44","journal-title":"Scand J Urol Nephrol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/biomet\/52.1-2.203","volume":"52","author":"EA Gehan","year":"1965","unstructured":"Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrica 52:203?223","journal-title":"Biometrica"},{"key":"CR6","first-page":"829","volume":"5","author":"RT Hoeft","year":"1982","unstructured":"Hoeft RT, Jones AG (1982) Treating metastasis with estramustine phosphate. Am J Nursing 5:829?830","journal-title":"Am J Nursing"},{"key":"CR7","first-page":"351","volume-title":"Vitamin and Hormones 33","author":"G J\u00f6nsson","year":"1975","unstructured":"J\u00f6nsson G, Olsson AM, Luttrop W, Cekan Z, Purvis K, Diczfalusy E (1975) Treatment of prostatic carcinoma with various types of estrogen derivatives. In: Munson PL, Diczfalusy E, Glover J, Olson RE (eds) Vitamin and Hormones 33. Academic Press, New York, pp 351?376"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/00365597709179957","volume":"11","author":"G J\u00f6nsson","year":"1977","unstructured":"J\u00f6nsson G, H\u00f6gberg B, Nilsson T (1977) Treatment of advanced prostatic carcinoma with estramustine phosphate (EstracytR). Scand J Urol Nephrol 11:231?238","journal-title":"Scand J Urol Nephrol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmj.4.5677.204","volume":"4","author":"M Kontturi","year":"1969","unstructured":"Kontturi M, Sotaniemi E (1969) Effect of oestrogen on liver function of prostatic carcer patients. Br Med J 4:204?205","journal-title":"Br Med J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1464-410X.1980.tb02915.x","volume":"52","author":"R K\u00fcss","year":"1980","unstructured":"K\u00fcss R, Khory S, Richard F, Fourcade F, Frantz P, Capelle JP (1980) Estramustine phosphate in the treatment of advanced prostatic cancer. Br J Urol 52:29?33","journal-title":"Br J Urol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000473302","volume":"6","author":"W Leistenschneider","year":"1980","unstructured":"Leistenschneider W, Nagel R (1980) Estracyt therapy of advanced prostatic cancer with special reference to control of therapy with cytology and DNA cytophotometry. Eur Urol 6:111?115","journal-title":"Eur Urol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0090-4295(76)90085-6","volume":"7","author":"JD Schmidt","year":"1976","unstructured":"Schmidt JD, Johnson DE, Scott WW, Gibbons RP, Prout GR, Murphy GP, Jacobi E, Chu TM, Gaeta JF, Joiner J, Saroff J (1976) Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. Urology 7:602?610","journal-title":"Urology"},{"key":"CR13","unstructured":"Vahlensieck W, Wegner G (1978) Comparison between continuous and intermittent oral Estracyttherapy. In: Rost A, Fiedler U (eds) Proc. II. International Symposium on the Treatment of Carcinoma of the Prostate. Berlin, pp 133?136"},{"key":"CR14","first-page":"147","volume":"55","author":"W Vahlensieck","year":"1980","unstructured":"Vahlensieck W, Wegner G (1980) Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt). Scand J Urol Nephrol Suppl 55:147?149","journal-title":"Scand J Urol Nephrol Suppl"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00261577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00261577\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00261577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T18:33:14Z","timestamp":1554316394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00261577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF00261577"],"URL":"https:\/\/doi.org\/10.1007\/bf00261577","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}